| [1] |
NI Yanying, ZHAI Chunyan, SHEN Ping, ZHANG Fanshuang, JIANG Zhongcai.
Proteomic characteristic analysis of adult H3K27-altered diffuse midline glioma
[J]. Basic & Clinical Medicine, 2026, 46(5): 607-613.
|
| [2] |
ZHAO Kaitao, MIAO Rui, WANG Wei.
Palladin promotes the stem features of gliomas cell line U251 through activating the mTOR pathway
[J]. Basic & Clinical Medicine, 2026, 46(2): 233-240.
|
| [3] |
CHEN Zhixin, LIU Xuan.
Progression of prostate-specific membrane antigen (PSMA) PET/CT in the diagnosis and treatment of prostate cancer
[J]. Basic & Clinical Medicine, 2026, 46(11): 1560-1565.
|
| [4] |
HAN Geyang, LI Yuke, HAN Wencong, ZHANG Zheng, LI Nan.
Advances in parameters for evaluating preoperative preparation of pheochromocytoma and paraganglioma
[J]. Basic & Clinical Medicine, 2026, 46(11): 1566-1572.
|
| [5] |
Zinati·NUERTAI, ROU Qian, ZHANG Meng, LIU Ying, CHENG Fang.
Spliceosome LSM4 inhibits the malignant progression of triple-negative breast cancer cell MDA-MB-231 through regulating DNA damage repair pathway
[J]. Basic & Clinical Medicine, 2026, 46(10): 1366-1374.
|
| [6] |
LU Wei, WANG Yanmin, LIU Bingchen, TAO Xin, WANG Shipeng, CAO Qiuye.
Berberine enhances the chemotherapy sensitivity of prostate cancer cell line 22RV1 to docetaxel
[J]. Basic & Clinical Medicine, 2026, 46(1): 39-45.
|
| [7] |
LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu.
Advances in the mechanism of action of the ring finger proteins family in breast cancer
[J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
|
| [8] |
AN Xin, JIA Lin, Mawusumu·MAMUT, HUANG Zhipeng, KahrimanI·SLAM, Rexiati·REHEMAN, Hairila·WULAMU, Kerbanjiang·ABULIKIM, Jesur·BATUR.
Effects of ANGPT1 on proliferation,invasion and angiogenesis of mouse prostate cancer cell line RM-1
[J]. Basic & Clinical Medicine, 2025, 45(9): 1165-1172.
|
| [9] |
MA Yue, HUANG Conggang, WANG Yuan, XU Wenqing, LUO Zhihua.
Ginkgo biloba extract inhibits the proliferation and migration of human glioma cell line U87
[J]. Basic & Clinical Medicine, 2025, 45(9): 1144-1150.
|
| [10] |
ZOU Qingbo, ZHANG Guochen, PAN Changjing.
Gypenoside inhibits the proliferation, migration and invasion of prostate cancer cell line PC-3
[J]. Basic & Clinical Medicine, 2025, 45(8): 1059-1065.
|
| [11] |
JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua.
Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration
[J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
|
| [12] |
WANG Meng, SHEN Xuejing, LIU Jia, SHANG Lulu, ZHANG Mo.
Probe-based label-free SERS for identification of breast cancer-induced serum metabolic profiles in patients
[J]. Basic & Clinical Medicine, 2025, 45(5): 651-657.
|
| [13] |
ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang.
TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
[J]. Basic & Clinical Medicine, 2025, 45(5): 575-582.
|
| [14] |
LI Yunfan, ZOU Jiaming, WANG Yucheng, JU Rui, GUO Lei.
CTO inhibits the in situ growth of glioblastoma in mice and regulates the metabolism and inflammatory phenotype of glioma-associated microglia
[J]. Basic & Clinical Medicine, 2025, 45(4): 478-485.
|
| [15] |
LUO Yubei, HUANG Jianjun, YANG Wenxiu, ZHANG Junhong, LI Jing, Robert Chunhua ZHAO, DOU Xiaowei.
Establishment and preliminary study of four patient-derived primary breast cancer cell lines
[J]. Basic & Clinical Medicine, 2025, 45(2): 183-188.
|